塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/17 | 5,689 | 5,709 | 5,570 | 5,579 | +140 | +2.6% | 2,827,600 |
2020/12/16 | 5,519 | 5,533 | 5,436 | 5,439 | -53 | -1% | 800,800 |
2020/12/15 | 5,568 | 5,582 | 5,488 | 5,492 | -58 | -1% | 924,900 |
2020/12/14 | 5,560 | 5,604 | 5,549 | 5,550 | -57 | -1% | 980,600 |
2020/12/11 | 5,620 | 5,666 | 5,581 | 5,607 | -13 | -0.2% | 1,043,000 |
2020/12/10 | 5,609 | 5,642 | 5,570 | 5,620 | +20 | +0.4% | 857,400 |
2020/12/09 | 5,601 | 5,673 | 5,575 | 5,600 | +9 | +0.2% | 918,100 |
2020/12/08 | 5,615 | 5,617 | 5,572 | 5,591 | -64 | -1.1% | 638,100 |
2020/12/07 | 5,623 | 5,669 | 5,605 | 5,655 | +45 | +0.8% | 549,500 |
2020/12/04 | 5,539 | 5,622 | 5,525 | 5,610 | +14 | +0.3% | 791,900 |
2020/12/03 | 5,596 | 5,642 | 5,571 | 5,596 | +6 | +0.1% | 1,281,900 |
2020/12/02 | 5,626 | 5,673 | 5,579 | 5,590 | -37 | -0.7% | 1,061,600 |
2020/12/01 | 5,630 | 5,687 | 5,602 | 5,627 | +34 | +0.6% | 686,000 |
2020/11/30 | 5,723 | 5,745 | 5,593 | 5,593 | -119 | -2.1% | 2,305,200 |
2020/11/27 | 5,729 | 5,753 | 5,681 | 5,712 | +12 | +0.2% | 1,096,500 |
2020/11/26 | 5,660 | 5,702 | 5,594 | 5,700 | +7 | +0.1% | 747,100 |
2020/11/25 | 5,723 | 5,768 | 5,687 | 5,693 | +115 | +2.1% | 1,345,800 |
2020/11/24 | 5,597 | 5,655 | 5,578 | 5,578 | +21 | +0.4% | 1,118,700 |
2020/11/20 | 5,561 | 5,609 | 5,530 | 5,557 | -45 | -0.8% | 1,068,300 |
2020/11/19 | 5,597 | 5,611 | 5,524 | 5,602 | -28 | -0.5% | 1,141,500 |
2020/11/18 | 5,553 | 5,685 | 5,549 | 5,630 | -10 | -0.2% | 888,500 |
2020/11/17 | 5,627 | 5,672 | 5,597 | 5,640 | +18 | +0.3% | 1,114,000 |
2020/11/16 | 5,607 | 5,688 | 5,585 | 5,622 | +10 | +0.2% | 880,100 |
2020/11/13 | 5,651 | 5,652 | 5,567 | 5,612 | -12 | -0.2% | 1,228,900 |
2020/11/12 | 5,698 | 5,735 | 5,562 | 5,624 | -156 | -2.7% | 1,805,400 |
2020/11/11 | 5,714 | 5,798 | 5,675 | 5,780 | +214 | +3.8% | 1,609,200 |
2020/11/10 | 5,675 | 5,690 | 5,541 | 5,566 | -34 | -0.6% | 1,253,700 |
2020/11/09 | 5,589 | 5,625 | 5,530 | 5,600 | +47 | +0.8% | 1,238,600 |
2020/11/06 | 5,498 | 5,582 | 5,442 | 5,553 | -27 | -0.5% | 1,444,900 |
2020/11/05 | 5,525 | 5,635 | 5,511 | 5,580 | +285 | +5.4% | 2,569,600 |
2020/11/04 | 5,259 | 5,324 | 5,181 | 5,295 | +142 | +2.8% | 1,591,400 |
2020/11/02 | 5,020 | 5,184 | 4,994 | 5,153 | +229 | +4.7% | 1,428,800 |
2020/10/30 | 4,880 | 5,039 | 4,761 | 4,924 | +39 | +0.8% | 1,919,200 |
2020/10/29 | 4,855 | 4,910 | 4,827 | 4,885 | -1 | ±0% | 748,300 |
2020/10/28 | 4,928 | 4,943 | 4,861 | 4,886 | -96 | -1.9% | 802,100 |
2020/10/27 | 5,040 | 5,045 | 4,957 | 4,982 | -53 | -1.1% | 712,300 |
2020/10/26 | 5,059 | 5,094 | 5,025 | 5,035 | -24 | -0.5% | 419,800 |
2020/10/23 | 5,124 | 5,165 | 5,059 | 5,059 | -5 | -0.1% | 592,300 |
2020/10/22 | 5,085 | 5,091 | 4,984 | 5,064 | -103 | -2% | 1,091,200 |
2020/10/21 | 5,205 | 5,210 | 5,160 | 5,167 | -50 | -1% | 736,200 |
2020/10/20 | 5,244 | 5,274 | 5,206 | 5,217 | -21 | -0.4% | 515,800 |
2020/10/19 | 5,224 | 5,268 | 5,224 | 5,238 | +84 | +1.6% | 618,200 |
2020/10/16 | 5,248 | 5,249 | 5,154 | 5,154 | -146 | -2.8% | 1,022,300 |
2020/10/15 | 5,374 | 5,409 | 5,277 | 5,300 | -104 | -1.9% | 1,038,100 |
2020/10/14 | 5,357 | 5,405 | 5,353 | 5,404 | +26 | +0.5% | 808,500 |
2020/10/13 | 5,460 | 5,460 | 5,357 | 5,378 | -107 | -2% | 880,600 |
2020/10/12 | 5,486 | 5,504 | 5,442 | 5,485 | -39 | -0.7% | 849,200 |
2020/10/09 | 5,513 | 5,530 | 5,478 | 5,524 | +44 | +0.8% | 1,068,700 |
2020/10/08 | 5,457 | 5,520 | 5,448 | 5,480 | +56 | +1% | 757,600 |
2020/10/07 | 5,444 | 5,452 | 5,398 | 5,424 | -75 | -1.4% | 729,200 |
1151~
1200
件表示中 / 3773件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,000円 | +20.9% | +10.6% | 2.59% | 12.06倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 776,600円 | +2.2% | +28.0% | 1.80% | 12.43倍 | 1.51倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 162,000円 | +0.9% | +380.2% | 4.81% | 22.32倍 | 1.92倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 254,500円 | -3.5% | -11.3% | 2.36% | 23.37倍 | 1.58倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 453,800円 | +0.1% | -3.4% | 3.53% | 30.85倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム